Post-Viral Illness: Long COVID Isn’t New
For decades, researchers and patients have documented chronic health issues that emerge after viral infections. These conditions often involve complex immune, neurological, or systemic symptoms and have long struggled for medical recognition and research support.
Long COVID is the most recent example, but not the first—and without continued investment, it risks following the now-familiar path of being misunderstood, underfunded, and left behind.
Long COVID and ME/CFS Share a Familiar Story
One of the clearest parallels is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating condition that often begins after viral illness. For decades, patients with ME/CFS were told their symptoms were psychological, even as research slowly uncovered patterns of immune dysfunction, energy metabolism issues, and neurological changes.
Today, long COVID patients face many of the same challenges: fatigue, brain fog, post-exertional crashes, and skepticism.
According to NIH-funded research, up to 4.5% of people who’ve had COVID-19 now meet the diagnostic criteria for ME/CFS—compared to just 0.6% of those who were never infected.
Chronic Conditions With Similar Dismissal
While the causes vary, several chronic illnesses have shared the same trajectory of delayed recognition and underinvestment:
Gulf War Illness (GWI)
Veterans of the 1990–91 Gulf War reported lasting fatigue, pain, and cognitive symptoms but faced years of disbelief before the condition was acknowledged and studied. Like long COVID, GWI involves immune and nervous system dysfunction.
Endometriosis
This immune-mediated disease affects at least 1 in 10 women, yet many still go years without a diagnosis. For decades, those with endometriosis were told their pain was normal or psychosomatic.
Fibromyalgia
Characterized by widespread pain and fatigue, fibromyalgia was long stigmatized as “not real.” It is now medically recognized, but gaps in research, understanding, and treatment persist.
A Pattern Worth Recognizing—and Breaking
These illnesses vary in origin and presentation, but they share key features:
They primarily affect women.
Their symptoms are often invisible or difficult to measure.
They face delays in diagnosis and lack reliable biomarkers.
Research funding has historically lagged far behind the disease burden.
Patients often report feeling dismissed or disbelieved.
Long COVID is at risk of becoming the next chapter in this pattern.
Sustained Support Is a Public Health Imperative
The early creation of the Office of Long COVID Research and Practice recognized that this condition is real, complex, and deserving of coordinated attention. Its planned closure has raised concerns about whether that recognition will continue.
History shows what happens when post-viral illness is ignored. We can do better now—by continuing to fund research, support patients, and treat long COVID not as an anomaly but as part of a larger, long-overdue conversation.